The lack of control when it comes to eating is one of the biggest reasons for why a lot of people find it so difficult to lose weight. Thanks to a recent discovery by scientists, however, overeating might potentially cease to be an issue. The researchers may have uncovered the trick to turn off the body’s “hunger alarm” system.
The study was done by University of Pennsylvania (UPenn) researchers who published their findings in the Cell Reports journal. The scientists basically identified which parts of the body act as biological notification systems that alerts the brain when a person feels hungry or full.
One of the minds behind the study is Penn's School of Arts and Sciences, Department of Biology assistant professor, J. Nicholas Betley. According to him, that the brains’ neurons can stave off hunger if the stomach basically tells it that it has already ingested food.
"When these neurons are firing, they're basically telling you, 'You'd better go get food; you're starving,'" Betley said. "They're a sensitive alarm system. And what this study conclusively demonstrated is that nutrients are the primary regulators of this alarm system."
As Futurism notes, up to 36.5 percent of adults in the U.S. have been diagnosed as obese, which is an alarming number regardless of what it is compared to. The conclusive proof that the researchers found might hold the key to helping the patients who have the poorest sense of self-control, the most vulnerable of which are children.
Being able to manipulate these neurons to signal the brain that enough food has been consumed or that the body does not need to be fed at any given moment would be a huge step in encouraging weight loss. It would also help in reducing the rate of serious health issues related to obesity, including type-2 diabetes and heart attacks.


FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Tabletop particle accelerator could transform medicine and materials science
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 



